[
    [
        {
            "time": "2023-10-18",
            "original_text": "华东医药遭控股股东远大集团合计质押830万股，占总股本0.47%。",
            "features": {
                "keywords": [
                    "华东医药",
                    "控股股东",
                    "远大集团",
                    "质押",
                    "股份"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华东医药遭控股股东远大集团合计质押830万股，占总股本0.47%。",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "和讯SGI公司|华东医药“不务正业”变身“华东医美”？从“生命之树”到“美貌之友”，制药不如医美香？",
            "features": {
                "keywords": [
                    "华东医药",
                    "医美",
                    "转型",
                    "制药",
                    "业务调整"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "和讯SGI公司|华东医药“不务正业”变身“华东医美”？从“生命之树”到“美貌之友”，制药不如医美香？",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "浙商证券维持水羊股份买入评级，水羊股份点评报告：厚积薄发，御泥坊品牌重塑踏上新征程。",
            "features": {
                "keywords": [
                    "浙商证券",
                    "水羊股份",
                    "买入评级",
                    "品牌重塑",
                    "御泥坊"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费品",
                    "美妆"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "浙商证券维持水羊股份买入评级，水羊股份点评报告：厚积薄发，御泥坊品牌重塑踏上新征程。",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "浙商证券：华东医药(000963.SZ)销售基因赋能，医美业务蓄势待发，维持“买入”评级。",
            "features": {
                "keywords": [
                    "浙商证券",
                    "华东医药",
                    "销售基因",
                    "医美业务",
                    "买入评级"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "浙商证券：华东医药(000963.SZ)销售基因赋能，医美业务蓄势待发，维持“买入”评级。",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "集采常态化加速行业洗牌，药企抢占新药与非医保赛道。",
            "features": {
                "keywords": [
                    "集采",
                    "常态化",
                    "行业洗牌",
                    "新药",
                    "非医保"
                ],
                "sentiment_score": -0.4,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "集采常态化加速行业洗牌，药企抢占新药与非医保赛道。",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "集采常态化加速行业洗牌，药企转型抢占新药与非医保赛道。",
            "features": {
                "keywords": [
                    "集采",
                    "常态化",
                    "行业洗牌",
                    "转型",
                    "新药",
                    "非医保"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "集采常态化加速行业洗牌，药企转型抢占新药与非医保赛道。",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]